Regulatory News Service

ENERGISME: Sandrine Cauvin joins Energisme as Administrative and Financial Director.

Retrieved on: 
Monday, September 20, 2021
Kepler, Software as a service, ISIN, SME, Administration, ODDO BHF, Regulatory News Service, CIIA, Chief, Metal, Business, Finance minister, Marketing, Industry, Company, Communication, Growth, SFAF, European Institute, Research, Certified International Investment Analyst, Acceleration, Euronext Growth, Security (finance), Financial services, Management

ENERGISME: Sandrine Cauvin joins Energisme as Administrative and Financial Director.

Key Points: 
  • ENERGISME: Sandrine Cauvin joins Energisme as Administrative and Financial Director.
  • Sandrine Cauvin said: "I am proud to join the Energisme team.
  • ENERGISME (ISIN code: FR0013399359/Ticker: ALNRG) has been listed on the Euronext Growth market since July 2020.
  • ENERGISME is eligible for SME personal equity plans and qualifies as a BPI Innovative Company and BPI Excellence.

Freelance.com: Signing of the memorandum of understanding and draft contribution agreement with Helvetic Payroll

Retrieved on: 
Monday, September 20, 2021
Mass meeting, Compliance, Efficiency, Solution, Regulatory News Service, HP, SME, The Future of Work and Death, Appendix, Heart, Financial services, Consultant, Group, BSAS, Acquisition, Growth, History, Security (finance), Bank, Public relations, Risk management, Health insurance, Animal

The acquisition of Helvetic Payroll reflects freelance.com's desire to expand the range of services offered to all of its clients, while building a benchmark player internationally.

Key Points: 
  • The acquisition of Helvetic Payroll reflects freelance.com's desire to expand the range of services offered to all of its clients, while building a benchmark player internationally.
  • The leader in wage portage in Switzerland, Helvetic Payroll supports both freelance consultants and international companies.
  • Changes in levels of activity combined with finalisation of the acquisition of Helvetic Payroll reinforce the Group's short- and medium-term turnover ambitions.
  • Following approval of the proposed merger with the Helvetic Payroll Group by the board of directors, a memorandum of understanding subject to conditions precedent was concluded and a draft contribution agreement signed on 17 September 2021.

Airtime Partecipazioni S.p.A. Admission to Trading Announcement

Retrieved on: 
Monday, September 20, 2021
The Company, EUR, Human, Compliance, Integration, Platform, Application, Euronext Paris, Regulatory News Service, Intention, Software, Knowledge, API, Environment, Industry, Group, THE, Company, Acquisition, Listing, Telecommunication, Admission, Technology, Uniloc USA, Inc. v. Microsoft Corp., Ecosystem, Science and technology in Asia, KYC, The Group, Security (finance), Mobile phone, Video game console, Online shopping, Sales, Airline

Trading of the shares on the Euronext Growth Market is expected to commence on or around September 22, 2021 (the "Admission to Trading").

Key Points: 
  • Trading of the shares on the Euronext Growth Market is expected to commence on or around September 22, 2021 (the "Admission to Trading").
  • ORLANDO TADDEO, CEO OF Airtime Partecipazioni S.p.A., COMMENTED:
    "We have been active in the industry across many verticals for over 20 years.
  • Airtime Partecipazioni S.p.A. owns 100% of the share capital of Airtime Technologies Limited based in Ireland ("Airtime Exchange"), which itself owns 100% of the share capital of Airtime Technologies USA Inc. based in the United States, together forming the Group.
  • Airtime Partecipazioni S.p.A. and its subsidiary Airtime Exchange are tech companies that provide fintech services.

Affluent Medical : Successful first post-operative adjustment of KaliosTM mitral ring.

Retrieved on: 
Thursday, September 16, 2021
Adrenal insufficiency, Degenerative disease, Regulatory News Service, NYHA, ISIN, Urinary incontinence, Classification, Patient, Mitral insufficiency, Aix-en-Provence, Rest, Prognosis, Mitral valve repair, Death, Laborde, Heart failure, Recurrence, Myocardial infarction, Medical device, Health insurance, KALIOS, AFFLUENT MEDICAL

Affluent Medical : Successful first post-operative adjustment of KaliosTM mitral ring.

Key Points: 
  • Affluent Medical : Successful first post-operative adjustment of KaliosTM mitral ring.
  • Affluent Medical (ISIN: FR0013333077 - ticker: AFME), a French medtech specialising in the international development and industrial scale-up of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and cardiac mitral insufficiency, today announces the success of the first ever KaliosTM mitral ring adjustment on a patient suffering from post-operative recurrence of severe mitral insufficiency.
  • Following successful implantation of a KaliosTM adjustable mitral ring, a simple trace of residual leakage was observed in a patient, who was operated in August 2020 for major mitral insufficiency (4+) [1] ,following a myocardial infarction.
  • Affluent Medical's Chief Medical Officer Prof. Franois Laborde confirmed that the KaliosTM device was a major breakthrough in treating mitral regurgitation and its recurrence, which happens between 30% and 40% of the redo mitral incompetence as reported in the medical literature.

ROCTOOL: Clinique and The Estée Lauder Companies Leverage Sustainable Packaging Technology With Roctool

Retrieved on: 
Thursday, September 16, 2021
Glass, Trex Company, Inc., TOM, PARIS, Regulatory News Service, NIOD, CEO, Technology, Estée Lauder, Clinique, Le Labo, Chief executive officer, Skin care, Estée Lauder Companies, Safety, Industry, Policy, Solution, Skin, Aveda, ELC, CSR, Senior, Temperature, Lotion, Research, Origin, DKNY, Distribution (marketing), Renewable energy, Cosmetics

767 Fifth Avenue New York, NY 10153

Key Points: 
  • 767 Fifth Avenue New York, NY 10153
    Clinique becomes the first prestige beauty brand to leverage Roctool's innovative & sustainable technology on an iconic bottle.
  • Luxury packaging design is an integral part in driving solutions in packaging sustainability, with innovations in technology playing a key role in elevating luxury packaging offerings.
  • "At The Estee Lauder Companies, we're continually investing and innovating at every step of our packaging process to help drive more responsible packaging solutions that enable our brands to deliver high-quality, luxury experiences to our consumers," said Daniel Ramos, Senior Vice President, Global Packaging, The Estee Lauder Companies.
  • Today, we are proud to work with The Estee Lauder Companies and Clinique to support their efforts in innovation and sustainability," said Mathieu Boulanger, CEO, Roctool.

Caterpillar Inc.: New 364-day credit facility

Retrieved on: 
Monday, September 13, 2021
Regulatory News Service, MUFG Bank, Credit, Facility, Agent, Credit agreements in South Africa, Citibank, Caterpillar Inc., Citibank Europe, The Borrowers, CIF

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • On September2, 2021, Caterpillar Inc. ("Caterpillar") entered into a Credit Agreement (the "364-Day Facility") among Caterpillar, Caterpillar Financial Services Corporation ("Cat Financial"), Caterpillar International Finance Designated Activity Company ("CIF") and Caterpillar Finance Kabushiki Kaisha ("CFKK" and, together with Caterpillar, Cat Financial and CIF, the "Borrowers"), certain financial institutions named therein (the "Banks"), Citibank, N.A.
  • (the "Agent"), Citibank Europe PLC, UK Branch (the "Local Currency Agent"), and MUFG Bank, Ltd. (the "Japan Local Currency Agent"), which provides an unsecured revolving credit facility to the Borrowers in an aggregate amount of up to $3.15 billion (the "364-Day Aggregate Commitment") that expires on September 2, 2022.
  • The 364-Day Facility replaces Caterpillar's prior 364-Day Facility, which was entered into on September 3, 2020.

RUBIS: Transactions carried out within the framework of share buyback program (excluding transactions within the liquidity agreement) - September 6 to 10, 2021, 2021

Retrieved on: 
Monday, September 13, 2021
Regulatory News Service, Company, Share repurchase, Cryptocurrency, Animal

RUBIS: Transactions carried out within the framework of share buyback program (excluding transactions within the liquidity agreement) - September 6 to 10, 2021, 2021

Key Points: 
  • RUBIS: Transactions carried out within the framework of share buyback program (excluding transactions within the liquidity agreement) - September 6 to 10, 2021, 2021
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • - September 6 to 10, 2021 -
    In accordance with the authorization granted by the Combined Shareholders' Meeting held on December 9, 2020 to implement a share buyback program, the Company operated, between September 6, 2021 and September 10, 2021, the purchases of its own shares in view of their cancelation presented below.
  • Aggregate presentation per day and per market:

NH TherAguix registration document approved by Autorité des Marchés Financiers as part of planned IPO on Euronext Growth Paris

Retrieved on: 
Monday, September 13, 2021

NH TherAguix, French biotech company specialized in the development of innovative nanomedicines for the treatment of cancer by radiotherapy, today announces the approval of its registration document by the Autorit des marchs financiers (the "AMF") under number I.21-048 dated 10 September 2021.

Key Points: 
  • NH TherAguix, French biotech company specialized in the development of innovative nanomedicines for the treatment of cancer by radiotherapy, today announces the approval of its registration document by the Autorit des marchs financiers (the "AMF") under number I.21-048 dated 10 September 2021.
  • The approval of the document marks the first step in the planned NH TherAguix IPO on the Euronext Growth market in Paris, which remains subject to favourable market conditions and AMF approval of the relevant prospectus.
  • Based on this observation, NH TherAguix has developed an innovative theranostic [1] approach in nanomedicine: AGuIX(R).
  • The registration document contains a detailed description of NH TherAguix, including its business activity, strategy and financial position, as well as the corresponding risk factors.

RUBIS: Availability of the 2021 Half-Year Financial Report

Retrieved on: 
Thursday, September 9, 2021

This document is a translation of the original French document and is provided for information purposes only.

Key Points: 
  • This document is a translation of the original French document and is provided for information purposes only.
  • In all matters of interpretation of information, views or opinions expressed therein, the original French version takes precedence over this translation.
  • Rubis announces today that its half-year financial report as of June 30, 2021 is available and has been filed with the Autorit des Marchs Financiers (the French Financial Markets Authority - AMF).
  • The 2021 half-year financial report can be downloaded from Rubis' website ( www.rubis.fr ), in the "Publications - Financial Reports" section.

RUBIS: Ongoing normalisation of the results - Growth drivers intact

Retrieved on: 
Thursday, September 9, 2021

Strong half-year results despite ongoing COVID restrictions:

Key Points: 
  • Strong half-year results despite ongoing COVID restrictions:
    H1 2021 volumes 2,650K m3, +7% vs H1 2020 and +2% vs H1 2019.
  • In the beginning of 2021, the Group anticipated an easing of restrictions linked to Covid in the second half of the year.
  • Supported by its strong financial position, the Group will continue to explore development opportunities, both through organic and external growth".
  • In this context, 10% EBIT growth vs H1 2020 and decline limited to 12% vs H1 2019 (pre-Covid year) represent good performance.